jofinЖурнал инфектологииJournal Infectology2072-6732IPO “АIDSSPbR"10.22625/2072-6732-2012-4-4S-31-34jofin-143Research ArticleСтатьиArticlesОпыт реализации пилотного проекта по профилактике ВПЧ инфекции вакциной Гардасил у девочек 9–14 лет в г. Санкт -ПетербургеExperience of realization of the pilot project on vaccination against HPV infection by Gardasil of girls in St.-PetersburgХаритС. М.KharitS. M.РудаковаА. В.RudakovaA. V.СимаходскийА. С.SimahodskijA. S.ЧерноваЛ. К.ChernovaL. K.Научно исследовательский институт детских инфекций ФМБА России, Санкт-ПетербургРоссияScientific research institute of children’s infections FMBА of Russia, Saint-PetersburgRussian FederationКомитет по здравоохранению правительства Санкт-Петербурга, Санкт-ПетербургРоссияCommittee on public health services of the government of Saint-Petersburg, Saint-PetersburgRussian Federation20121509201444S3134Copyright © Харит С.М., Рудакова А.В., Симаходский А.С., Чернова Л.К., 20142014Харит С.М., Рудакова А.В., Симаходский А.С., Чернова Л.К.Kharit S.M., Rudakova A.V., Simahodskij A.S., Chernova L.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.niidi.ru/jofin/article/view/143
.
.
ReferencesHuman papillomavirus vaccines WHO position paper. Weekly epidemiological record. – 10 APRIL 2009, 84th YEAR. – V. 15, № 84. – Р. 117–132.Human papillomavirus vaccines WHO position paper. Weekly epidemiological record. – 10 APRIL 2009, 84th YEAR. – V. 15, № 84. – Р. 117–132.Report of the meeting on HPV Vaccine Coverage and Impact Monitoring 16-17 November 2009 Geneva, Switzerland. Ordering code: WHO/IVB/10.05 May 2010, www.who.int/vaccinesdocuments/Report of the meeting on HPV Vaccine Coverage and Impact Monitoring 16-17 November 2009 Geneva, Switzerland. Ordering code: WHO/IVB/10.05 May 2010, www.who.int/vaccinesdocuments/The Immunological Basis for Immunization Series Module 19: Human papillomavirus infection. World Health Organization 2010, Printed in May 2011.The Immunological Basis for Immunization Series Module 19: Human papillomavirus infection. World Health Organization 2010, Printed in May 2011.Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials The Future II Study Group. www. thelancet.com – 2007. –V. 369. – June 2. – Р. 1861–1868.Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials The Future II Study Group. www. thelancet.com – 2007. –V. 369. – June 2. – Р. 1861–1868.Slade, В.A. Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine / В.A. Slade [et al.] // JAMA. – August 19, 2009. – V. 302, № 7. – Р. 750–757.Slade, В.A. Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine / В.A. Slade [et al.] // JAMA. – August 19, 2009. – V. 302, № 7. – Р. 750–757.Fairley, C.K. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women / C.K. Fairley [et al.] // Sex. Transm. Infect. – 2009. – № 85. – Р. 499–502.Fairley, C.K. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women / C.K. Fairley [et al.] // Sex. Transm. Infect. – 2009. – № 85. – Р. 499–502.Donovan, B. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data / B. Donovan [et al.] // infection.thelancet. com. – 2011. – V. 2. – P. 131–137.Donovan, B. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data / B. Donovan [et al.] // infection.thelancet. com. – 2011. – V. 2. – P. 131–137.Read, T.R.H.. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme / T.R.H. Read [et al.] / Sex Transm. Infect. – 2011. – doi:10.1136/sextrans-2011-050234 group.bmj.com on October 6, 2011 – Published by sti.bmj.com Downloaded from group.bmj.comRead, T.R.H.. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme / T.R.H. Read [et al.] / Sex Transm. Infect. – 2011. – doi:10.1136/sextrans-2011-050234 group.bmj.com on October 6, 2011 – Published by sti.bmj.com Downloaded from group.bmj.comBrotherton, J.M.L. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study / J.M.L. Brotherton [et al.] // thelancet.com. – 2011. – V. 377. – June 18. – P. 2085-2092.Brotherton, J.M.L. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study / J.M.L. Brotherton [et al.] // thelancet.com. – 2011. – V. 377. – June 18. – P. 2085-2092.Bauer, H. Evidence of hpv vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2009 / H. Bauer, G. Wright, J. Chow // Sex Transm. Infect. – July 2011. – V. 87, Suppl 1. – P. 25–26.Bauer, H. Evidence of hpv vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2009 / H. Bauer, G. Wright, J. Chow // Sex Transm. Infect. – July 2011. – V. 87, Suppl 1. – P. 25–26.Joura, E.A. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data / E.A. Joura [et al.] // BMJ. – 2012. – V. 344. – e1401 doi: 10.1136/bmj.e1401 (Published 27 March 2012).Joura, E.A. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data / E.A. Joura [et al.] // BMJ. – 2012. – V. 344. – e1401 doi: 10.1136/bmj.e1401 (Published 27 March 2012).Rothman, S.M. Marketing HPV Vaccine Implications for Adolescent Heal and Medical Professionalism / S.M. Rothman, D.J. Rothman // JAMA. – August 19, 2009. – V. 302, №. 7. – Р. 781–786.Rothman, S.M. Marketing HPV Vaccine Implications for Adolescent Heal and Medical Professionalism / S.M. Rothman, D.J. Rothman // JAMA. – August 19, 2009. – V. 302, №. 7. – Р. 781–786.Гомберг, М.А. Распространенность аногенитальных бородавок в клинической практике специалистов в РФ / М.А. Гомберг, В.Н. Прилепская // Всероссийский форум «Мать и дитя», 2012.Гомберг, М.А. Распространенность аногенитальных бородавок в клинической практике специалистов в РФ / М.А. Гомберг, В.Н. Прилепская // Всероссийский форум «Мать и дитя», 2012.
The authors declare that there are no conflicts of interest present.